David J Venzon Selected Research

AZD 6244

10/2023	Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas.
11/2022	Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity.
1/2020	Selumetinib in Children with Inoperable Plexiform Neurofibromas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David J Venzon Research Topics

Disease

17	Neoplasms (Cancer) 10/2023 - 10/2004
10	Infections 01/2021 - 04/2009
8	Viremia 11/2020 - 09/2009
7	Prostatic Neoplasms (Prostate Cancer) 09/2023 - 01/2002
4	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2023 - 01/2019
3	Plexiform Neurofibroma 10/2023 - 01/2020
3	Neurofibromatosis 1 (Neurofibromatosis Type I) 10/2023 - 01/2020
3	Body Weight (Weight, Body) 01/2020 - 10/2015
3	Multiple Myeloma 10/2019 - 07/2017
2	Bronchiolitis Obliterans Syndrome 01/2021 - 01/2020
2	COVID-19 01/2021 - 01/2021
2	Disease Progression 01/2020 - 01/2019
2	Hypoalbuminemia 10/2019 - 06/2013
1	Pain (Aches) 10/2023
1	Inflammation (Inflammations) 01/2023
1	Capillary Leak Syndrome 01/2023
1	Cancer Pain 11/2022
1	Residual Neoplasm 12/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Virus Diseases (Viral Diseases) 01/2020
1	Nausea 01/2020
1	Diarrhea 01/2020
1	Exanthema (Rash) 01/2020
1	Vomiting 01/2020
1	Paronychia 01/2020
1	Hyperbilirubinemia 10/2019
1	HIV Infections (HIV Infection) 10/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Monoclonal Gammopathy of Undetermined Significance 01/2018
1	Smoldering Multiple Myeloma 01/2018
1	Thymoma (Thymic Carcinoma) 11/2016
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Thrombotic Microangiopathies 09/2014
1	Cardiac Arrhythmias (Arrythmia) 06/2013
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 06/2013
1	Cardiotoxicity 06/2013

Drug/Important Bio-Agent (IBA)

9	VaccinesIBA 01/2023 - 09/2009
6	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2002
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2004
5	AndrogensIBA 09/2023 - 12/2004
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 01/2019
3	AZD 6244IBA 10/2023 - 01/2020
3	AntibodiesIBA 01/2021 - 01/2018
3	Human Serum Albumin FDA LinkGeneric 01/2020 - 10/2015
3	CytokinesIBA 01/2019 - 12/2010
3	AIDS VaccinesIBA 10/2018 - 01/2018
3	AntigensIBA 11/2016 - 09/2009
2	Immunotoxins (Immunotoxin)IBA 01/2023 - 12/2012
2	Lenalidomide (CC 5013)FDA Link 10/2019 - 07/2017
2	carfilzomibIBA 10/2019 - 07/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2019 - 07/2017
1	enzalutamideIBA 12/2021
1	SteroidsIBA 01/2021
1	Interferon Type IIBA 01/2021
1	pomalidomideIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	CD40 Ligand (CD40L)IBA 01/2020
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020
1	Broadly Neutralizing AntibodiesIBA 01/2019
1	Galactosylceramides (Galactocerebrosides)IBA 01/2019
1	GP 140IBA 10/2018
1	Complement System Proteins (Complement)IBA 10/2018
1	Interleukin-15 (Interleukin 15)IBA 01/2018
1	InflammasomesIBA 01/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2018
1	Granzymes (Granzyme)IBA 01/2018
1	env Gene ProductsIBA 01/2018
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2018
1	B-Cell Maturation AntigenIBA 01/2018
1	Chimeric Antigen ReceptorsIBA 01/2018
1	Testosterone (Sustanon)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Cancer VaccinesIBA 01/2017
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	MesothelinIBA 11/2016
1	Surface Antigens (Surface Antigen)IBA 11/2016
1	discorhabdin HIBA 01/2016
1	makaluvamine FIBA 01/2016
1	discorhabdin LIBA 01/2016
1	discorhabdin WIBA 01/2016
1	discorhabdin BIBA 01/2016
1	LuciferasesIBA 01/2016
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 01/2016
1	HLA-DRB1 Chains (HLA DRB1)IBA 09/2014
1	Cell ExtractsIBA 04/2014
1	TroponinIBA 06/2013
1	MagnesiumIBA 06/2013
1	romidepsin (FK228)FDA Link 06/2013
1	PotassiumIBA 06/2013
1	Histone Deacetylase InhibitorsIBA 06/2013
1	Immunoglobulin G (IgG)IBA 02/2013
1	Protons (Proton)IBA 11/2012

Therapy/Procedure

14	Therapeutics 09/2023 - 09/2006
3	Cell Transplantation 11/2023 - 01/2020
3	Transplantation 01/2022 - 01/2019
2	Aftercare (After-Treatment) 12/2021 - 11/2005
1	Homologous Transplantation 01/2019
1	Immunotherapy 01/2017
1	Castration 01/2017